The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase - Hacke,W.; Albers,G.; Al-Rawi,Y. (Stroke, 2005)